Pioglitazone and Metformin Hydrochloride
- Product NDC
- 42291-513
- 11-digit product format
- 422910513
- Labeler code
- 42291
- Product ID
- 42291-513_63a0189b-1147-838e-e053-2991aa0a8dc2
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Pioglitazone and Metformin Hydrochloride
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- AvKARE, Inc.
- Application
- ANDA091155
- Marketing category
- ANDA
- Marketing start
- 2015-03-06
- Marketing end
- 0000-00-00
- Substance
- PIOGLITAZONE HYDROCHLORIDE; METFORMIN HYDROCHLORIDE
- Active strength
- 15 mg/1; mg/1
- Pharmacologic classes
- Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR alpha [CS],PPAR gamma [CS],Thiazolidinedione [EPC],Thiazolidinediones [CS],Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator Receptor gamma Agonist [EPC],Biguanide [EPC],Biguanides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record